Are you a researcher, clinician, health care professional, or generally interested in the topic of neuroimmunological diseases?
The Acute Optic Neuritis Network is pleased to invite you to the Acute Optic Neuritis Treatment Update Day on May 5th 2023 in Tel Aviv, Israel. This will be a hybrid event. You can find more details here.
ACON is an international consortium, focused on studying diagnosis and treatment of subjects with a first-ever optic neuritis. The broad enrollment of patients of all ethnicities and from all continents ensures an excellent representation of the heterogeneity of this condition. Many of the enrolled patients will then be diagnosed with NMOSD, MOGAD or MS and are eligible for preventive immunotherapy.
The ACON offers an expert Treatment Day giving an overview of acute and long-term treatment Options in neuroimmunological diseases.
Debates, Talks, & Panel Discussions
Acute optic neuritis treatment
Long-term MOGAD and NMOSD treatment
Please find attached the program and register here.
IMSVISUAL is holding its annual symposium in conjunction with the ACTRIMS Forum 2023 in San Diego, California on Saturday, February 25 from 12:30 – 1:30 PM PST. Please see the symposium schedule below. Click here to register for the ACTRIMS Forum 2023 and attend our session live.
12:30 - 12:35 PM
Introduction Shiv Saidha
12:35 - 12:50 PM
In Vivo Retinal Imaging in Translational Research Frederike Oertel
12:50 - 1:00 PM
Quantifying Retrograde Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis Sargis Manukyan
1:00 - 1:10 PM
Integration of MS Risk Genes with Single Cell Transcriptomics in the Retina and Predictors of Retinal Layer Thicknesses Samantha Hao
1:10 - 1:20 PM
Attractor-Like Changes in Dynamic Brain Connectivity Relate to Clinical Disability in Multiple Sclerosis Andrew Russo
1:20 - 1:30 PM
The Effects of Myelin Loss, Repair, and Remyelination Therapies on Visual Cortical Function Gustavo Della Flora Nunes
IMSVISUAL held its annual symposium in conjunction with the ACTRIMS Forum 2022 in West Palm Beach, Florida on Friday, February 25 from 4:00-5:15 pm ET. Please see the symposium schedule below as well as the full recording from the session.
AP3.1 Optic Nerve MS Project Lucas Schirmer, Heidelberg University
AP3.2 Functional OCT Methods: Development and Application to NMO, Alzheimer’s, and MS David Bissig, UC Davis
AP3.3 In vivo Modelling of Autoantibody-mediated Optic Neuritis Oliver Gramlich, Iowa City VA Health Care System
AP3.4 Characterization of Multiple Sclerosis Pathology in Retinal Ganglion Cells and Axonal Bundles by Adaptive Optics-Optical Coherence Tomography Katherine Kovalick, University of Maryland Medical Center
AP3.5 Deploying Machine Learning for Classification of Optic Neuritis Subtypes using Ocular Fundus Photographs as a Biomarker Etienne Benard-Seguin, University of Calgary
IMSVISUAL will hold a virtual symposium in conjunction with the ACTRIMS Forum 2021, which will take place virtually February 25-27, 2021. The IMSVISUAL Symposium is available to all registrants of the ACTRIMS Forum 2021
Symposium Chairs: E. Ann Yeh, The Hospital for Sick Children and Philipp Albrecht, University Hospital Düsseldorf
Visual Outcome Metrics in MS: What are the Opportunities? Heather Moss, Stanford University
Socioeconomic Disparity Correlates with Faster Inner Retinal Layer Thickness in Multiple Sclerosis Elena Vasileiou, Johns Hopkins University School of Medicine
Identification of Optical Coherence Tomography Phenotypes and their Relationship with Patient Outcomes in Youth with Demyelinating Syndromes: Preliminary Results of an Unsupervised Machine Learning Analysis Beyza Cifti-Kavakioglu, The Hospital for Sick Children
Neuroprotective Effects of the Sphingosine 1 Phosphate Receptor 1/5 Modulator RP-101074 on Retinal Neurodegeneration and Visual Function in Light-Induced Photoreceptor Loss Christina Hecker, UKD
It is our pleasure to invite you to our IMSVISUAL symposium at ACTRIMS Forum 2019 (being held in Dallas, Texas, February 28 – March 2), to discuss updates on vision research in multiple sclerosis and related disorders. For the third consecutive year we are fortunate to have secured ACTRIMS as our sponsor.
The symposium, integrated into the ACTRIMS program and CME accredited, will take place on Thursday, February 28th from 12:30pm – 1:45pm. Please see below the confirmed agenda for talks/speakers during the session. This symposium/session is open to all attendees of the ACTRIMS Forum 2019.
I think this will be an exciting symposium with presentations from
several groups representing existing IMSVISUAL member sites from
around the world.
We look forward to seeing you all in Dallas!
IMSVISUAL symposium at the ACTRIMS Forum 2019, Thursday, February 28th
Session Chairs: Laura Balcer, NYU Langone Health and Elena Martínez-Laspiscina, Hospital Clínic de Barcelona
1: “Is there progressive retinal damage in neuromyelitis optica spectrum disorders?” Friedemann Paul, NeuroCure Clinical Research Center
2: “Smartphone Suite of Visual Tests in Multiple Sclerosis” Randy Kardon, University of Iowa Health Care
3: “Corneal Confocal Microscopy: “A rapid non-invasive technique to image neurodegeneration” Ioannis Petropoulos, Weill Cornell Medicine – Qatar
4: “Dynamics of retinal layer atrophy in normal aging and multiple sclerosis” Elias Sotirchos, Johns Hopkins University
5: “Retinal imaging in EAE for translational neuroprotection studies” Philipp Albrecht, Heinrich-Heine-Universität Düsseldorf